tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Tryptamine Therapeutics Announces Cessation of Securities
Company AnnouncementsTryptamine Therapeutics Announces Cessation of Securities
6d ago
TYP
Tryptamine Therapeutics Announces 2025 AGM Date and Advances in Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Announces 2025 AGM Date and Advances in Clinical Trials
20d ago
TYP
Tryptamine Therapeutics Showcases TRP-8803 at Neuropsychiatric Summit
PremiumCompany Announcements
Tryptamine Therapeutics Showcases TRP-8803 at Neuropsychiatric Summit
26d ago
TYP
Tryptamine Therapeutics Issues New Securities on ASX
PremiumCompany Announcements
Tryptamine Therapeutics Issues New Securities on ASX
27d ago
TYP
Tryptamine Therapeutics Releases 2025 Corporate Governance Statement
PremiumCompany Announcements
Tryptamine Therapeutics Releases 2025 Corporate Governance Statement
1M ago
TYP
Tryptamine Therapeutics Reports Increased Income and Reduced Losses
PremiumCompany AnnouncementsTryptamine Therapeutics Reports Increased Income and Reduced Losses
1M ago
TYP
Tryptamine Therapeutics Announces Proposed Issue of Securities
Premium
Company Announcements
Tryptamine Therapeutics Announces Proposed Issue of Securities
2M ago
TYP
Tryptamine Therapeutics Partners with Imperial College London for EEG-Based Biomarker Development
Premium
Company Announcements
Tryptamine Therapeutics Partners with Imperial College London for EEG-Based Biomarker Development
2M ago
TYP
Tryptamine Therapeutics Expands Capital with New ASX Quotation
PremiumCompany Announcements
Tryptamine Therapeutics Expands Capital with New ASX Quotation
2M ago
TYP
Tryptamine Therapeutics Secures $2.6M to Advance TRP-8803 Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Secures $2.6M to Advance TRP-8803 Clinical Trials
2M ago
TYP
Tryptamine Therapeutics Initiates Groundbreaking Trial for Binge Eating Disorder Treatment
PremiumCompany Announcements
Tryptamine Therapeutics Initiates Groundbreaking Trial for Binge Eating Disorder Treatment
2M ago
Tryptamine Therapeutics Launches Groundbreaking Trial for Binge Eating Disorder Treatment
PremiumCompany Announcements
Tryptamine Therapeutics Launches Groundbreaking Trial for Binge Eating Disorder Treatment
2M ago
Tryptamine Therapeutics Launches Groundbreaking Trial for Binge Eating Disorder
PremiumCompany AnnouncementsTryptamine Therapeutics Launches Groundbreaking Trial for Binge Eating Disorder
2M ago
Tryptamine Therapeutics Launches Pioneering Trial for Binge Eating Disorder
Premium
Company Announcements
Tryptamine Therapeutics Launches Pioneering Trial for Binge Eating Disorder
2M ago
TYP
Tryptamine Therapeutics Bolsters Team for Groundbreaking Clinical Trial
Premium
Company Announcements
Tryptamine Therapeutics Bolsters Team for Groundbreaking Clinical Trial
3M ago
TYP
Tryptamine Therapeutics Advances Psilocybin Product Development
PremiumCompany Announcements
Tryptamine Therapeutics Advances Psilocybin Product Development
3M ago
TYP
Tryptamine Therapeutics to Launch World-First Trial for Binge Eating Disorder Treatment
PremiumCompany Announcements
Tryptamine Therapeutics to Launch World-First Trial for Binge Eating Disorder Treatment
3M ago
TYP
Tryptamine Therapeutics Releases Options from Escrow to Boost Clinical Developments
PremiumCompany Announcements
Tryptamine Therapeutics Releases Options from Escrow to Boost Clinical Developments
4M ago
Tryptamine Therapeutics Appoints New Chairman to Strengthen Strategic Direction
PremiumCompany Announcements
Tryptamine Therapeutics Appoints New Chairman to Strengthen Strategic Direction
4M ago
Tryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder
PremiumCompany AnnouncementsTryptamine Therapeutics to Launch Groundbreaking Trial for Binge Eating Disorder
4M ago
Tryptamine Therapeutics Announces Cessation of Securities
Premium
Company Announcements
Tryptamine Therapeutics Announces Cessation of Securities
5M ago
TYP
Tryptamine Therapeutics Releases Options from Escrow and Advances Clinical Trials
Premium
Company Announcements
Tryptamine Therapeutics Releases Options from Escrow and Advances Clinical Trials
5M ago
TYP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >